Parkinson's disease (PD) is caused by the degeneration of dopaminergic neurons of
substantia nigra projecting to striatum. The cause of idiopathic PD is obscure, and most …

Several exciting approaches for restorative therapy in Parkinson's disease have emerged
over the past two decades. This review initially describes experimental and clinical data …

During the past decade, there has been a remarkable progress in our understanding of the
biology of Parkinson disease (PD), which has been translated into searching for novel …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by a progressive
loss of the dopaminergic neurons of the substantia nigra pars compacta (SNpc). Although …

The main pathology underlying disease symptoms in Parkinson's disease (PD) is a
progressive degeneration of nigrostriatal dopamine (DA) neurons. No effective disease …

Intrabrain transplantation of chromaffin cell aggregates of the Zuckerkandl9s organ, an extra-
adrenal paraganglion that has never been tested for antiparkinsonian treatment, induced …

Parkinson's disease is a neurodegenerative condition characterized by motor impairments
caused by the selective loss of dopaminergic neurons in the substantia nigra. Levodopa is …

Parkinson's disease is a chronic progressive condition that causes disability and reduction
of quality of life. Symptomatic treatments are effective in the early disease; however, with …

Over the last decade, molecular biology has progressively developed, leading to new
technology with subsequent clinical application for various cerebral diseases including …

During the last few years, recombinant viral vectors derived from adenovirus (Ad), adeno-
associated virus (AAV) or lentivirus (LV) have been developed into highly effective vehicles …